Close

Analyst Ratings for Nektar Therapeutics (NKTR) [Buys]

NKTR Rating Summary

NKTR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NKTR
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $6.46 (+91.1%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 40%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2021 Benchmark Aydin Huseynov Upgrade Buy
(Hold)
20.00
(N/A)
13.45
(3.38)
-74.87% Details
3/4/2020 Barclays Peter Lawson New Coverage Overweight
(N/A)
30.00
(N/A)
20.10
(3.38)
-83.18% Details
Like NKTR Ratings? Also take a look at BMY, TWST, LLY, LEG

NKTR Ratings News